24/7 Market News Snapshot 17 June, 2025 – Beyond Air, Inc. Common Stock (NASDAQ:XAIR)

June 17, 2025

DENVER, Colo., 17 June, 2025 (www.247marketnews.com) – (NASDAQ:XAIR) are discussed in this article.
Beyond Air, Inc. (NASDAQ:XAIR) has generated significant market excitement, with its shares rising sharply from an opening price of $0.19 to $0.283, marking an impressive 57.57% increase following the previous close of $0.180. This notable price movement underscores a growing investor interest, as evidenced by a robust trading volume of 30.32 million shares. Such bullish momentum reflects heightened market confidence in Beyond Air’s innovative strategies and potential impact in the biotech arena.

In a recent announcement, Beyond Air reported remarkable financial growth for the fiscal year ending March 31, 2025, showcasing a 220% increase in revenues, reaching $3.7 million, up from $1.2 million in the preceding year. This growth is fueled by the successful deployment of the LungFit® PH system in over 45 hospitals, raising clinician awareness of its benefits compared to traditional nitric oxide delivery systems. The company is forging ahead with an expansion strategy that includes international partnerships covering markets with a combined population exceeding 2 billion.

Looking ahead, Beyond Air has set ambitious revenue targets for the upcoming quarter, aiming for at least $1.7 million for the period ending June 30, 2025, and a broader fiscal year 2026 revenue projection ranging between $12 million to $16 million. Chairman and CEO Steve Lisi remarked on the company’s rapidly building commercial momentum, which is now reflected in the growth of its topline results.

Furthermore, Beyond Air has submitted a Pre-Market Approval (PMA) supplement for its second-generation LungFit® PH device to the FDA, anticipating it will unlock significant market opportunities once approved. Complementing its strategic initiatives, the company has appointed Robert Goodman, a seasoned healthcare executive, to its Board of Directors, effective June 13, 2025. With a focus on respiratory care, neurodevelopmental disorders, and oncology, Beyond Air is poised for an impactful year ahead, reinforcing its commitment to enhancing patient care globally.

Related news for (XAIR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.